This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Millipore Announces Full Commercial Availability Of Handheld Automated Cell Counter

Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it has begun full commercial shipments of its Scepter™ Handheld Automated Cell Counter to customers worldwide.

The Scepter instrument miniaturizes Coulter cell counting technology found in much larger instruments into a portable device the size of an automated pipette. A graphical display reports the cell count and average cell volume within 20 seconds of inserting the sensor into a cell culture sample. The product, which was announced in the fourth quarter of 2009, has generated strong interest from leading government and commercial laboratories. Millipore expects to continue to increase shipments in North America, Europe, Japan, Asia and Latin America through the remainder of the year.

“We continue to move aggressively to bring innovation and productivity enhancements to the life science research market,” said John Sweeney, Vice President of Millipore’s Life Science business. “With the introduction of the Scepter instrument, we now have a range of tools that help life scientists simplify tedious, repetitive tasks and improve the reproducibility of their experiments.”

In addition to counting cells, the Scepter instrument gives researchers immediate insights into cell health. For example, scientists are using the instrument to monitor the transformation of stem cells to a differentiated state. The novel instrument is also being evaluated for such diverse applications as identifying cell types prior to forensic analysis and analyzing the size and consistency of particles during the commercial production of ink.

Additional Resources

About Millipore

Millipore (NYSE: MIL) is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees worldwide. For more information, visit


Research. Development. Production.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MIL $2.05 1.99%
AAPL $118.22 -0.07%
FB $105.76 1.50%
GOOG $759.80 2.30%
TSLA $234.04 1.60%


Chart of I:DJI
DOW 17,822.34 +102.42 0.58%
S&P 500 2,088.70 +8.29 0.40%
NASDAQ 5,123.3430 +14.6770 0.29%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs